Authors: Goss, BGS Blakey, D Barry, MD George, GA

Citation: Bgs. Goss et al., Modelling of infectious spreading in heterogeneous polymer oxidation II. Refinement of stochastic model and calibration using chemiluminescence of polypropylene, POLYM DEGR, 74(3), 2001, pp. 523-532

Authors: Fisher, KD Ulbrich, K Subr, V Ward, CM Mautner, V Blakey, D Seymour, LW

Citation: Kd. Fisher et al., A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression, GENE THER, 7(15), 2000, pp. 1337-1343

Authors: Prince, HM Rischin, D Toner, GC Seymour, JF Blakey, D Gates, P Eerhard, S Chapple, P Quinn, M Brettell, M Juneja, S Wolf, M Januszewicz, EH Richardson, G Scarlett, J Briggs, P

Citation: Hm. Prince et al., Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxelwith peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study, BONE MAR TR, 26(9), 2000, pp. 955-961

Authors: Prince, HM Toner, GC Seymour, JF Blakey, D Gates, P Eerhard, S Chapple, P Wall, D Quinn, M Juneja, S Wolf, M Januszewicz, EH Richardson, G Scarlett, J Briggs, P Brettell, M Rischin, D

Citation: Hm. Prince et al., Docetaxel effectively mobilizes peripheral blood CD34(+) cells, BONE MAR TR, 26(5), 2000, pp. 483-487

Authors: Prince, HM Millward, MJ Rischin, D Blakey, D Francis, P Gates, P Chapple, P Quinn, M Juneja, S Wolf, M Januszewicz, EH Seymour, JF Brettell, M Strickland, A Zalcberg, J Richardson, G Scarlett, J Briggs, P Toner, GC

Citation: Hm. Prince et al., Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel withperipheral blood progenitor cell and filgrastim support for metastatic andlocally advanced breast cancer: Results of a phase I study, ANN ONCOL, 10(4), 1999, pp. 479-481

Authors: Edge, M Forder, C Hennam, J Lee, I Tonge, D Hardern, I Fitton, J Eckersley, K East, S Shufflebotham, A Blakey, D Slater, A

Citation: M. Edge et al., Engineered human carboxypeptidase B enzymes that hydrolyse hippuryl-L-glutamic acid: reversed-polarity mutants, PROTEIN ENG, 11(12), 1998, pp. 1229-1234